Pharma EHS & sustainability consultancy - Adroitix

1. BLOOD PLASMA FRACTIONATION Plasma Collection Plasma is collected from healthy donors at plasma donation centres. The plasma is first tested extensively for safety. It is then fractionated to isolate the desired proteins. Many litres of plasma are required to produce sufficient quantities of the purified proteins. Fractionation Process In the fractionation process, the plasma is thawed and treated to precipitate certain proteins which are removed by centrifugation and filtration. The supernatant is then subjected to various processes like salting out, chromatography, electrophoresis, and precipitation to isolate the various components. Pharma EHS & sustainability consultancy helps pharmaceutical companies integrate Environment, Health, and Safety practices with sustainable operations. It ensures compliance with global EHS standards, waste reduction, energy efficiency, and green facility design. By addressing risk management and eco-friendly strategies, it supports safe workplaces, regulatory adherence, and long-term sustainability goals while enhancing efficiency and reducing environmental impact in pharma manufacturing. Major Plasma Proteins Some of the major proteins isolated from plasma fractionation include: www.adroitix.com

2. Albumin which helps maintain blood volume and pressure. Immunoglobulin G (IgG) which contains antibodies and is used to treat immune deficiencies. Coagulation factors like Factor VIII and Factor IX which are used to treat bleeding disorders like haemophilia. The global coagulation factors market size was valued at USD 10.4 billion in 2022. Storage Requirements The purified plasma proteins require very cold temperatures for stability. They are frozen at - 30°C or below and stored in deep freezers prior to distribution. Careful temperature control is critical throughout the transportation and storage process. The proteins are formulated with stabilizers to help maintain effectiveness under frozen storage. Applications Plasma fractionation has enabled the isolation of proteins vital for treating bleeding disorders, immunodeficiencies, burns, shock, and other medical conditions. The advancements in fractionation technology have greatly improved plasma’s utility in saving lives. Continued plasma collection and research are key to meet the growing worldwide demand. Key points 1. Availability of the Blood plasm for the processing. 2. Plasma Handling, Storage of Raw plasma in negative temperature ( -30 ˚ C). 3. Plasma sampling and plasma bag cutting. 4. Solvent Handling (Considering Cohn Fractionation method). Source url: https://adroitix.com/blog/blood-plasma-fractionation www.adroitix.com